Localization of 1,25-dihydroxyvitamin D3 receptor (VDR) expression in human prostate

Journal of Steroid Biochemistry and Molecular Biology

Volumn 66, Issue 3, 1998, Pages 121-127

  Kivineva, Merja ^a   Bläuer, Merja ^a   Syvälä, Heimo ^b   Tammela, Teuvo ^c   Tuohimaa, Pentti ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL RECEPTOR;

ARTICLE; CELL GROWTH; DRUG EFFECT; DRUG RECEPTOR BINDING; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; PROSTATECTOMY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR AFFINITY; STROMA CELL; TARGET CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; CELL NUCLEUS; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; OSTEOSARCOMA; PEPTIDE FRAGMENTS; PROSTATE; RATS; RECEPTORS, CALCITRIOL; STROMAL CELLS; TISSUE DISTRIBUTION; TISSUE EMBEDDING; TUMOR CELLS, CULTURED;

EID: 0032145803     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00054-5     Document Type: Article

References (44)

1. 3. Biochemical Journal. 316:1996;361-371.
2. 3 in gynecologic neoplasms. Gynecologic Oncology. 44:1992;131-136.
3. Zhuang S. -H., Schwartz G. G., Cameron D., Burnstein K. L. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines. Molecular and Cellular Endocrinology. 126:1997;83-90.
4. 3 receptors and actions in human prostate cancer cell lines. Endocrinology. 132:1993;1952-1960.
5. 3 and the regulation of human cancer cell replication. Proceedings of the Society for Experimental Biology and Medicine. 191:1989;221-226.
6. Konety B. R., Schwartz G. G., Acierno J. S. Jr., Becich M. J., Getzenberg R. H. The role of vitamin D in normal prostate growth and differentiation. Cell Growth and Differentiation. 7:1996;1563-1570.
7. Schwartz G. G., Hulka B. S. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Research. 10:1990;1307-1311.
8. Hanchette C. L., Schwartz G. G. Geographic patterns of prostate cancer mortality. Evidence for a protective role of ultraviolet radiation. Cancer. 70:1992;2861-2869.
9. Schwartz G. G. Multiple sclerosis and prostate cancer: What do their similar geographies suggest? Neuroepidemiology. 11:1992;244-254.
10. Corder E. H., Guess H. A., Hulka B. S., Friedman G. D., Sadler M., Vollmer R. T., Lobaugh B., Drezner M. K., Vogelman J. H., Orentreich N. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiology, Biomarkers and Prevention. 2:1993;467-472.
11. Ingles S. A., Ross R. K., Yu M. C., Irvine R. A., La-Pera G., Haile R. W., Coetzee G. A. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. Journal of National Cancer Institute. 89:1997;166-170.
12. 3 is independent of nuclear receptor binding. Journal of Biological Chemistry. 270:1995;15962-15965.
13. 3 are mediated exclusively through the genomic signaling pathway. Endocrinology. 137:1996;1554-1561.
14. Walters M. R. Newly identified actions of the vitamin D endocrine system. Endocrine Reviews. 13:1992;719-764.
15. 3] binding sites in male sex organs of the mouse: an autoradiographic study. Journal of Histochemistry and Cytochemistry. 37:1989;1083-1086.
16. 3 receptor in rat reproductive tissues. Histochemistry and Cell Biology. 105:1996;7-15.
17. 3 on primary cultures of human prostatic cells. Cancer Research. 54:1994;805-810.
18. Baker A. R., McDonnel D. P., Hughes M., Crisp T. M., Mangelsdorf D. J., Haussler M. R., Pike J. W., Shine J., O'Malley B. W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proceedings of the National Academy of Sciences of the U.S.A. 85:1988;3294-3298.
19. 3 specific regulation of growth, morfology, and fibronectin in a human osteosarcoma cell line. Journal Cellular Physiology. 123:1985;401-409.
20. 3 receptor in rats. Biochemical and Biophysical Research Communications. 137:1986;742-747.
21. Hurst H. C., Masson N., Jones N. C., Lee K. A. W. The cellular transcription factor CREB corresponds to activating transcription factor 47 (ATF-47) and forms complexes with a group of polypeptides related to ATF-43. Molecular and Cellular Biology. 10:1990;6192-6203.
22. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with Folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
23. Mäenpää P., Mahonen A., Pirskanen A. Hormonal regulation of vitamin D receptor levels and osteocalcin synthesis in human osteosarcoma cells. Calcified Tissue International. 49 Suppl. 1991;S85-S86.
24. Mahonen A., Mäenpää P. Steroid hormone modulation of vitamin D receptor levels in human MG-63 osteosarcoma cells. Biochemical and Biophysical Research Communications. 205:1994;1179-1186.
25. Cattoretti G., Pileri S., Parravicini C., Becker M. H. G., Poggi S., Bifulco C., Key G., D'Amato L., Sabattini E., Feudale E., Reynolds F., Gerdes J., Rilke F. Antigen unmasking on formalin-fixed, paraffin embedded tissue sections. Journal of Pathology. 171:1993;83-98.
26. 28k in human kidney. American Journal of Physiology. 266:1994;F477-F485.
27. Berger U., Wilson P., McClelland R. A., Colston K., Haussler M. R., Pike J. W., Coombes R. C. Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. Journal of Clinical Endocrinology and Metabolism. 67:1988;607-613.
28. 3 receptors in normal and psoriatic skin. Journal Investigative Dermatology. 97:1991;230-239.
29. 3 in skin. Cell and Tissue Research. 238:1984;489-496.
30. 3-dependent rapid and estrogen-dependent slow reorganization of vitamin D receptors. Journal of Cell Biology. 111:1990;2385-2395.
31. Barsony J., Renyi I., McKoy W. Subcellular distribution of normal and mutant vitamin D receptors in living cells. Studies with a novel fluorescent ligand. Journal of Biological Chemistry. 272:1997;5774-5782.
32. Chang C., Chodak G., Sarac E., Takeda H., Liao S. Prostate androgen receptor: immunohistological localization and mRNA characterization. Journal of Steroid Biochemistry. 34:1989;311-313.
33. Husmann D. A., Wilson C. M., McPhaul M. J., Tilley W. D., Wilson J. D. Antipeptide antibodies to two distinct regions of the anrogen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate. Endocrinology. 126:1990;2359-2368.
34. Schulze H., Claus S. Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry. Prostate. 16:1990;331-343.
35. Konishi N., Nakaoka S., Hiasa Y., Kitahori Y., Ohshima M., Samma S., Okajima E. Immunohistochemical evaluation of estrogen receptor status in benign prostatic hypertrophy and in prostate carcinoma and the relationship to efficacy of endocrine therapy. Oncology. 50:1993;259-263.
36. Mobbs B. G., Liu Y. Immunohistochemical localization of progesterone receptor in benign and malignant human prostate. Prostate. 16:1990;245-251.
37. Yen P. M., Liu Y., Palvimo J. J., Trifiro M., Whang J., Pinsky L., Janne O. A., Chin W. W. Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription. Molecular Endocrinology. 11:1997;162-171.
38. 3 receptors in T 47D breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology. 45:1993;257-263.
39. 3 receptors: divergent effects on mouse and rat intestine. Endocrinology. 111:1982;1400-1402.
40. Horst R. L., Goff J. P., Reinhardt T. A. Advancing age results in reduction of intestinal and bone 1,25-dihydroxyvitamin D receptor. Endocrinology. 126:1990;1053-1057.
41. 3 and intestinal vitamin D receptor concentrations in normal women. Journal of Clinical Endocrinology and Metabolism. 75:1992;176-182.
42. 3 in the androgen-dependent LNCaP cells. Biochemical and Biophysical Research Communications. 223:1996;141-146.
43. 3 in NRP-152 rat prostatic epithelial cells. Journal of Cellular Physiology. 166:1996;231-239.
44. Dube V. E., Farrow G. M., Greene L. F. Prostatic adenocarcinoma of ductal origin. Cancer. 32:1973;402-409.